Abstract:Background Inflammatory myopathies (IM) and Myasthenia gravis (MG) are two well-recognised and distinctive neuromuscular diseases. The association of myasthenia gravis (MG) and inflammatory myositis (IM) is rare and often only one of the diseases is diagnosed. The coexistence of MG and IM might be associated with thymoma. Even less common is the association of IM (polymyositis or dermatomyositis) and myasthenia gravis in the absence of thymoma. Objectives Here, we report a case series of 6 patients with concurrent MG and IM who were followed at the Neuromuscular Disease Unit (NMDU) at a tertiary referral centre in Vancouver, British Columbia. We also conducted literature review on clinical characteristics, diagnostic challenge and management of this condition. Methods In this study, we retrospectively examined patients seen at NMDU from 2004 to 2017 who had diagnosis of concurrent MG and IM. We reviewed medical records to assess their clinical presentations, laboratory findings, imaging studies and electrophysiological features. The data is presented descriptively. Results We identified 6 patients with MG-IM overlap. Three patients had simultaneous onset of MG and IM, 2 of whom presented with myasthenia crisis and fulminant myositis. In the other 3 patients, MG was the initial presentation and IM occurred 3–11 years after MG. Diagnosis of MG was confirmed with clinical features, electromyography and/or serology. All had symptoms of MG with predominant ocular or bulbar weakness. Among these 6 patients, 3 had underlying thymic pathology including two benign thymoma and one stage IV thymoma; all 3 patients had Acetylcholine Receptor (AChR) Antibody. Of the 3 patients with no thymic pathology by computed tomography (CT) or thymectomy, 1 had high positive AChR antibody and 2 were negative. Four patients had biopsies confirming the diagnosis of dermatomyositis or polymyositis. The other 2 patients declined biopsy; however, their MRI and EMG findings were consistent with IM. Only one patient had typical dermatomyositis rash. Among the 3 patients with underlying thymic pathology, thymoma were resected; all 3 were treated with high dose glucocorticoid, IVIG, and methotrexate with complete remission after 2 years. Of the 3 patients with no thymic pathology identified, one patient (AChR+) was in remission on mycophenolate and passed away from pancreatic cancer; two patients (AChR-) had refractory MG and IM, and both responded to rituximab. Conclusions In summary, this is one of the largest case series with MG-IM overlap with or without thymic pathology. It is very important to recognise such association and the different pattern of muscle involvement because therapies may be adjusted to treat both conditions. In patients with thymic pathology, conventional disease modifying agents, IVIG and glucocorticoid in addition to thymoma resection appear to be effective. In patients with refractory MG and myositis who were AChR negative, rituximab may be effective. Disclosure of Interest None declared

Report of a case of necrotizing autoimmune myopathy with thymoma-associated myasthenia gravis

Case report: Multi-antibody-positive myasthenia gravis concomitant myositis associated with thymoma

Thymoma-Associated Myasthenia Gravis With Myocarditis

Analysis on clinical features of necrotizing autoimmune myopathy

Case report: Complex paraneoplastic syndromes in thymoma with nephrotic syndrome, cutaneous amyloidosis, myasthenia gravis, and Morvan's syndrome

Thymoma‐associated autoimmune encephalitis with myasthenia gravis: Case series and literature review

AB0777 Inflammatory Myositis Associated with Myasthenia Gravis with and Without Thymic Pathology: Case Series and Literature Review

Thymoma With Myasthenia Gravis: A Study of Two Cases

Unique association of anti-GABAA receptor encephalitis and myasthenia gravis in a patient with type A thymoma

Concurrent inflammatory myopathy and myasthenia gravis with or without thymic pathology: A case series and literature review.

Giant cell polymyositis associated with myasthenia gravis and thymoma.

Presence of Multiple Autoimmune Antibodies Involved in Concurrent Myositis and Myocarditis and Myasthenia Gravis Without Thymoma: A Case Report

Thymoma-Related Chest Pain and Dyspnea in a Middle-Aged Caucasian Female With Myasthenia Gravis and Good's Syndrome: A Case Report

Sequential development of diffuse panbronchiolitis and myasthenia gravis after thymectomy for thymic neoplasm: a case report

Anti-NXP2-antibody-positive immune-mediated necrotizing myopathy associated with acute myeloid leukemia: A case report.

Prognostic Analysis of Thymoma-Associated Myasthenia Gravis (MG) in Chinese Patients and Its Implication of MG Management: Experiences from a Tertiary Hospital

An extremely rare case of thymic squamous cell carcinoma complicated with B3 thymoma and myasthenia gravis: a case report

Different Characteristics of Thymomas With and Without Myasthenia Gravis

Immunotherapy Reversed Myopathy but Not Cardiomyopathy in a Necrotizing Autoimmune Myopathy Patient with Positive Anti-Srp and MDA-5 Autoantibodies

Advances in the Pathogenesis of Thymus and Myasthenia Gravis

Immune checkpoint-mediated myositis and myasthenia gravis: A case report and review of evaluation and management